Universitätsklinikum Erlangen - Hautklinik
About Universitätsklinikum Erlangen - Hautklinik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
University Hospital Erlangen
3
Amgen
2
Concert Pharmaceuticals
2
Hoffmann-La Roche
2
LEO Pharma
2
Actelion
1
Alkahest, Inc.
1
Aristea Therapeutics, Inc.
1
Charite University, Berlin, Germany
1
Coherus Biosciences, Inc.
1
Clinical Trials at Universitätsklinikum Erlangen - Hautklinik
During the past decade, Universitätsklinikum Erlangen - Hautklinik conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 13 clinical trials were completed, i.e. on
average, 130% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
2002-10-01
2007-06-01
Completed
62
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
2002-10-01
2012-05-01
Completed
23
Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma
2003-07-01
2014-03-01
Completed
82
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
2007-01-01
2011-07-01
Terminated
44
Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept
2010-01-01
2013-04-01
Completed
174
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
2010-11-19
2018-09-24
Completed
72
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
2010-08-01
2011-07-01
Completed
1,013
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitätsklinikum Erlangen - Hautklinik" #1 sponsor was "Pfizer" with 6 trials, followed by "University Hospital Erlangen" with 3 trials
sponsored, "Amgen" with 2 trials sponsored, "Concert Pharmaceuticals" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Erlangen - Hautklinik"
#1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator, "Shire" with 1 trials as a collaborator and "Ticeba GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Universitätsklinikum Erlangen - Hautklinik
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Erlangen - Hautklinik" are
"Psoriasis" (7 trials), "Melanoma (Skin)" (4 trials), "Alopecia Areata" (2 trials), "Plaque Psoriasis" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Universitätsklinikum Erlangen - Hautklinik" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Erlangen - Hautklinik
Most popular intervention types in "Universitätsklinikum Erlangen - Hautklinik" are "Drug" (20 trials), "Biological" (7 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Etanercept" (3 trials), "Apremilast" (2 trials), "Vemurafenib" (2 trials) and "therapeutic autologous dendritic cells" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Erlangen - Hautklinik
The vast majority of trials in "Universitätsklinikum Erlangen - Hautklinik" are
26 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Erlangen - Hautklinik
Currently, there are NaN active trials in "Universitätsklinikum Erlangen - Hautklinik".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Universitätsklinikum Erlangen - Hautklinik,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Erlangen - Hautklinik, 5 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 0 trials that are defined as “Not Applicable".